Cogent Biosciences
COGT
COGT
144 hedge funds and large institutions have $547M invested in Cogent Biosciences in 2023 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 61 increasing their positions, 30 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.77% more ownership
Funds ownership: 106.31% → 108.08% (+1.8%)
38% less capital invested
Capital invested by funds: $886M → $547M (-$339M)
71% less funds holding in top 10
Funds holding in top 10: 7 → 2 (-5)
Holders
144
Holding in Top 10
2
Calls
$1.3M
Puts
$652K
Top Buyers
| 1 | +$25.8M | |
| 2 | +$21.4M | |
| 3 | +$15.7M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$8.38M |
| 5 |
State Street
Boston,
Massachusetts
|
+$6.96M |
Top Sellers
| 1 | -$62.6M | |
| 2 | -$12.6M | |
| 3 | -$12.6M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$10.1M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$9.75M |